XML 37 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities    
Earnings $ 4,913 $ 2,050
Adjustments to reconcile earnings to net cash provided by operating activities:    
Depreciation and amortization 2,526 2,452
Deferred income tax (recovery)/expense 983 (51)
Changes in unrealized (gain)/loss on derivative instruments, net (Note 11) (1,005) 319
Earnings from equity investments (1,159) (1,076)
Distributions from equity investments 1,442 1,090
Impairment of long-lived assets 105 1,076
Impairment of goodwill 0 1,019
Loss on dispositions 0 76
Other 51 101
Changes in operating assets and liabilities (451) 943
Net cash provided by operating activities 7,405 7,999
Investing activities    
Capital expenditures (3,928) (4,584)
Long-term investments and restricted long-term investments (1,018) (1,091)
Distributions from equity investments in excess of cumulative earnings 285 1,243
Additions to intangible assets (136) (491)
Proceeds from dispositions 0 1,913
Other 0 (12)
Affiliate loans, net (232) (50)
Net cash (used in)/provided by investing activities (5,029) (3,072)
Financing activities    
Net change in short-term borrowings 245 (196)
Net change in commercial paper and credit facility draws 3,365 (2,358)
Debenture and term note issues, net of issue costs 2,553 3,537
Debenture and term note repayments (2,994) (3,757)
Sale of noncontrolling interests in subsidiaries 0 1,289
Contributions from noncontrolling interests 10 23
Distributions to noncontrolling interests (194) (637)
Contributions from redeemable noncontrolling interests 0 62
Distributions to redeemable noncontrolling interests 0 (264)
Common shares issued 18 17
Preference share dividends (287) (268)
Common share dividends (4,480) (2,254)
Redemption of preferred shares held by subsidiary (Note 10) (300) 0
Other (60) (5)
Net cash provided by/(used in) financing activities (2,124) (4,811)
Effect of translation of foreign denominated cash and cash equivalents and restricted cash (17) 23
Net increase/(decrease) in cash and cash equivalents and restricted cash 235 139
Cash and cash equivalents and restricted cash at beginning of period 637 587
Cash and cash equivalents and restricted cash at end of period $ 872 $ 726